MetLife, MiMedx Group Fall into Friday’s 52-Week Low Club
Regulus Therapeutics, MagneGas, MiMedx, and MetLife all posted new 52-week lows Friday.
Regulus Therapeutics, MagneGas, MiMedx, and MetLife all posted new 52-week lows Friday.
The top analyst upgrades, downgrades and other research calls from Monday include AXA Equitable, Dollar General, Five Below, Macy's, SM Energy, Trade Desk and Whirlpool.
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Broadcom, Caterpillar, Cree, GrubHub, Intel, 3M, MetLife and Verizon.
The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot Locker, McDonald's and Pfizer.
Tuesday was a down day for the U.S. markets, and in fact the worst day that we’ve seen in a long time. This is also the second consecutive day for the markets…
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that could radically change how Wall Street and Main Street evaluate companies ahead.
24/7 Wall St. wanted to evaluate how the Wall Street analysts were valuing Brighthouse Financial after its spin-off from MetLife.
The top analyst upgrades, downgrades and other research calls from Thursday include Akamai Technologies, Alexion Pharmaceuticals, Altria, Chipotle Mexican Grill, MEI Pharma, Netflix and PayPal.
As of the start of May of 2017, just 21 members of the S&P 500 Index were valued at less than 10 times expected earnings per share.
The top analyst upgrades, downgrades and initiations seen om Monday include Apple, Dow Chemical, GoPro, Netflix, Snap, FedEx and MetLife.
The top analyst upgrades, downgrades and initiations seen on Thursday include Hasbro, Johnson & Johnson, Mattel, MetLife, United Rentals, United Technologies and Williams Companies.
Stocks have pulled back off their highs from the end of 2016 and that Dow Jones Industrial Average (DJIA) 20,000 mark remains elusive. The major market indexes were indicated a tad lower…
For "value" to be found in financial stocks, one metric that is always insightful is a review of profitable companies that are trading at discounts to their stated book values.
While the Merrill Lynch US 1 list has slightly underperformed the S&P 500 year to date, it has outperformed since inception by a large margin. The stocks are among the highest conviction…
In a recent research note, the analysts at Merrill Lynch make a big move by removing two blue chips from the firm's well-respected US 1 list of stocks to buy.